The tweet was deleted by the author.
But we saved everything 🙂.
Spencer Hakimian, an aspiring entrepreneur, is seeking opportunities following significant price reductions in pharmaceuticals. His inquiry about a master list of drug prices that have reportedly fallen 1,500% since January highlights his intent to capitalize on these market shifts.
Hakimian's interest underscores a broader trend where entrepreneurs are actively looking to leverage industry developments to propose new business models. The notable drug price decline, if verified, may offer a lucrative landscape for new ventures aiming at affordable healthcare solutions.